These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38528382)

  • 1. Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization.
    Bayrak Durmaz MS; Unutmaz DG; Demir M; Goksel O; Dursun AB; Bavbek S
    Allergy Asthma Immunol Res; 2024 Mar; 16(2):142-153. PubMed ID: 38528382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
    Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
    World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Skin Tests in the Diagnosis of Immediate Hypersensitivity Reactions to Taxanes: Results of a Multicenter Study.
    Pagani M; Bavbek S; Dursun AB; Bonadonna P; Caralli M; Cernadas J; Cortellini G; Costantino MT; Gelincik A; Lucchini G; Castells M
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):990-997. PubMed ID: 30292919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
    Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol.
    Kim HH; Seo J; Ahn YH; Kim H; Yoon JE; Suh JH; Kang DY; Lee SY; Kang HR
    Front Allergy; 2022; 3():786822. PubMed ID: 35386661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization.
    Villarreal-González RV; González-Díaz S; Vidal-Gutiérrez O; Canel-Paredes A; de la Cruz-de la Cruz C; García-Campa M; López-Méndez A; Alvarado-Ruiz S; Castells M
    Clin Rev Allergy Immunol; 2023 Oct; 65(2):231-250. PubMed ID: 37589840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions.
    Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A
    J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
    Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
    J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of rapid drug desensitization in children.
    Esenboga S; Akarsu A; Ocak M; Gur Cetinkaya P; Sahiner UM; Sekerel BE; Soyer O
    Pediatr Allergy Immunol; 2022 Mar; 33(3):e13759. PubMed ID: 35338724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of the diagnosis of hypersensitivity reactions to antineoplastic and biological agents: experience with drug provocation test.
    Queirós Gomes J; Pereira Dias LP; Barreira P; Barradas Lopes J; Sousa MJ; Cadinha S; Malheiro D
    Eur Ann Allergy Clin Immunol; 2023 May; ():. PubMed ID: 37133313
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
    Goksel O; Goksel T; Cok G; Karakus H; Bacakoglu F; Goker E; Uslu R; Erdinc M
    Int J Clin Oncol; 2015 Apr; 20(2):395-404. PubMed ID: 25056643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
    Caiado J; Brás R; Paulino M; Costa L; Castells M
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Hypersensitivity Reactions to Taxanes.
    Picard M
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.